The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.
- 15 April 1991
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (8) , 3160-3164
- https://doi.org/10.1073/pnas.88.8.3160
Abstract
Glanzmann thrombasthenia is an autosomal recessive bleeding disorder characterized by a decrease or absence of functional platelet glycoprotein (GP) IIb-IIIa (alpha IIb beta 3) integrin receptors. Although thrombasthenia is a rare disorder, its occurrence is increased in some regions of the world where intracommunity marriage and consanguinity are commonplace, resulting in increased expression of autosomal recessive traits. We have been studying two populations having an unusually high frequency of Glanzmann disease, Iraqi Jews and Arabs living in Israel, and were able to distinguish the populations on the basis of immunodetectable GPIIIa and platelet surface vitronectin receptor (alpha v beta 3) expression. In this article, we describe molecular genetic studies based on use of the PCR that have allowed us to characterize platelet mRNA sequences encoding GPIIb and GPIIIa from patients in these populations. In six of six Iraqi-Jewish families studied, cDNA sequence analysis identified an 11-base deletion within exon 12 of the GPIIIa gene. This mutation produces a frameshift leading to protein termination shortly before the transmembrane domain of GPIIIa. In contrast, a 13-base deletion encompassing the splice acceptor site of exon 4 of the GPIIb gene was found in three of five Arab kindreds studied. This deletion results in forced alternative splicing to a downstream AG acceptor, producing a 6-amino acid deletion in the GPIIb protein, including a single cysteine residue. These nucleotide sequence variations were exploited to design a rapid, PCR-based oligonucleotide dot-blot hybridization test for both pre- and postnatal diagnosis of Glanzmann disease. These studies demonstrate the heterogeneity of Glanzmann thrombasthenia in different populations, and its homogeneity within geographically restricted populations, and offer insight into the requirements for integrin surface expression.Keywords
This publication has 29 references indexed in Scilit:
- A β 3 Integrin Mutation Abolishes Ligand Binding and Alters Divalent Cation-Dependent ConformationScience, 1990
- Organization of the gene for platelet glycoprotein IIbBiochemistry, 1990
- Immunoblot analysis of platelet glyeoprotein IIb in patients with Glanzmann thrombasthenia in IsraelBritish Journal of Haematology, 1989
- The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.Journal of Clinical Investigation, 1989
- Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction.Journal of Clinical Investigation, 1988
- Structure of platelet glycoprotein IIIa. A common subunit for two different membrane receptors.Journal of Clinical Investigation, 1988
- Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes.The Journal of cell biology, 1987
- Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi‐Jewish and Arab populations of Israel: comparison of techniques for carrier detectionBritish Journal of Haematology, 1986
- Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa.Proceedings of the National Academy of Sciences, 1986
- Molecular Defects in Interactions of Platelets with the Vessel WallNew England Journal of Medicine, 1984